Gastroparesis With Diabetes Mellitus
7
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis
Laparoscopic Implantation of a Gastric Pacemaker in the Treatment of Gastroparesis
Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
Trial Investigating Efficacy of G-POEM
PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis
Safety and Efficacy of GPOEM in the Treatment of Gastroparesis